New Cholesterol Treatment Could Save Over 330,000 Lives Annually in Thailand
A major meta-analysis published in a leading medical journal signals a potential new standard in cholesterol care. International researchers, led by a professor from a Polish university, analyzed data from 14 trials involving more than 100,000 high-risk patients. The study found that adding ezetimibe to statin therapy lowers LDL cholesterol more effectively than statins alone and reduces deaths from cardiovascular disease.
For Thai readers, the findings are highly relevant because cardiovascular disease remains a top health challenge in Thailand. The research reports a 19% decrease in all-cause mortality and a 16% drop in cardiovascular deaths when ezetimibe is added to statins. Major cardiovascular events also fell by 18%, underscoring the potential to save lives and reduce economic burdens from heart disease.
